Ligand Pharmaceuticals Ratios and Metrics

Market cap in millions CAD. Fiscal year is July - June.

Millions CAD. Fiscal year is Jul - Jun.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '25 Aug 12, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Market Capitalization	150	10	15	22	-
Market Cap Growth	-12.17%	-30.29%	-32.05%	-	-
Enterprise Value	152	11	15	21	-
Last Close Price	1.39	0.12	0.20	0.35	-
PS Ratio	91.91	7.94	12.65	46.01	-
PB Ratio	-48.32	-6.49	-21.50	23.87	-
P/TBV Ratio	-	-	-	23.87	-
EV/Sales Ratio	92.82	8.27	12.79	42.80	-
Debt / Equity Ratio	-0.49	-0.49	-0.73	0.92	-
Asset Turnover	1.84	1.18	0.61	0.27	-
Inventory Turnover	9.86	5.92	10.50	-	-
Quick Ratio	0.06	0.07	0.22	1.32	6.29
Current Ratio	0.13	0.23	0.47	1.47	6.97
Return on Equity (ROE)	-	-	-5361.51%	-666.06%	-
Return on Assets (ROA)	-129.94%	-111.56%	-172.77%	-79.61%	-
Return on Capital (ROIC)	-	-	-425.00%	-114.54%	-
Earnings Yield	-1.29%	-19.73%	-40.63%	-25.04%	-
FCF Yield	-	-12.14%	-27.57%	-17.73%	-
Buyback Yield / Dilution	-13.99%	-7.07%	-8.73%	-86.13%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.